Genus plc (LON:GNS – Get Free Report)’s stock price traded up 2.2% on Wednesday. The company traded as high as GBX 2,406 and last traded at GBX 2,390. 178,452 shares traded hands during trading, a decline of 75% from the average daily volume of 724,650 shares. The stock had previously closed at GBX 2,338.
Analyst Ratings Changes
Separately, Berenberg Bank reiterated a “buy” rating and set a GBX 3,350 price target on shares of Genus in a report on Tuesday, October 13th. Three equities research analysts have rated the stock with a Buy rating. According to MarketBeat, Genus has an average rating of “Buy” and an average target price of GBX 3,216.67.
View Our Latest Research Report on GNS
Genus Trading Down 0.6%
The company has a quick ratio of 1.08, a current ratio of 2.22 and a debt-to-equity ratio of 14.02. The firm’s 50-day moving average price is GBX 2,245.87 and its 200 day moving average price is GBX 2,409.33. The company has a market capitalization of £1.47 billion, a P/E ratio of 5.36, a P/E/G ratio of 2.87 and a beta of 0.91.
Genus (LON:GNS – Get Free Report) last posted its quarterly earnings data on Thursday, September 10th. The company reported GBX 110.30 EPS for the quarter. Genus had a net margin of 43.35% and a return on equity of 44.90%. As a group, equities research analysts predict that Genus plc will post 70.96 earnings per share for the current year.
Genus declared that its board has authorized a stock repurchase program on Thursday, September 10th that permits the company to buy back £60 million in outstanding shares. This repurchase authorization permits the company to buy up to 3.9% of its shares through open market purchases. Share repurchase programs are generally an indication that the company’s board believes its shares are undervalued.
Insider Activity
In other Genus news, insider Jorgen Kokke sold 50,236 shares of the company’s stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of GBX 2,151, for a total value of £1,080,576.36. Insiders own 0.78% of the company’s stock.
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Further Reading
- Five stocks we like better than Genus
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
